The treatment of pyoderma in children.

Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother (1992) 1.22

Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo. Antimicrob Agents Chemother (1988) 1.02

Natural history of impetigo. II. Etiologic agents and bacterial interactions. J Clin Invest (1972) 1.00

Sultamicillin in the treatment of superficial skin and soft tissue infections in children. Antimicrob Agents Chemother (1987) 0.76

Topical versus systemic antibiotics in the treatment of acute superficial skin infections. J Natl Med Assoc (1979) 0.75

Protocol for the systematic review of the prevention, treatment and public health management of impetigo, scabies and fungal skin infections in resource-limited settings. Syst Rev (2016) 0.75

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (1995) 34.97

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science (1996) 21.81

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10

Decay characteristics of HIV-1-infected compartments during combination therapy. Nature (1997) 13.68

Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science (1998) 12.05

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med (1999) 7.07

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nat Med (1996) 6.14

Declining blood lead levels and cognitive changes in moderately lead-poisoned children. JAMA (1993) 4.46

Hemangiomas in children. N Engl J Med (1999) 4.40

Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet (1999) 4.36

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat Med (2000) 4.08

Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol (1999) 3.79

HIV-1 drug resistance in newly infected individuals. JAMA (1999) 3.49

Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med (2001) 3.37

Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy. J Virol (1999) 3.15

Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol (1991) 2.79

Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir. Antimicrob Agents Chemother (1998) 2.67

Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J Virol (1997) 2.60

HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med (1998) 2.50

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. J Clin Invest (1999) 2.42

Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med (1999) 2.33

The inaccuracy in using interviews to estimate patient reliability in taking medications at home. Med Care (1969) 2.32

Evaluation of the effectiveness of comprehensive and continuous pediatric care. Pediatrics (1971) 2.22

Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. J Clin Invest (2000) 2.21

Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease. Antimicrob Agents Chemother (1996) 2.13

Resistance to human immunodeficiency virus type 1 protease inhibitors. Antimicrob Agents Chemother (1998) 1.92

Successful treatment of juvenile hemangiomas with prednisone. J Pediatr (1968) 1.91

Juvenile xanthogranuloma. J Am Acad Dermatol (1997) 1.90

Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol (1997) 1.85

Optic gliomas in children with neurofibromatosis type 1. J Pediatr (1989) 1.76

Purpura in infants and children. J Am Acad Dermatol (1997) 1.72

Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy. J Infect Dis (1999) 1.70

Community advisory boards: their role in AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS. Health Soc Work (1998) 1.67

Kwashiorkor in the United States: fad diets, perceived and true milk allergy, and nutritional ignorance. Arch Dermatol (2001) 1.66

Cutis marmorata telangiectatica congenita: report of 22 cases. J Am Acad Dermatol (1989) 1.63

Epidermal and other congenital organoid nevi. Curr Probl Pediatr (1975) 1.58

Ritonavir and saquinavir combination therapy for the treatment of HIV infection. AIDS (1999) 1.58

Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase. N Engl J Med (1980) 1.58

The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol (1978) 1.56

Intraepidermal type VII collagen. Evidence for abnormal intracytoplasmic processing of a major basement membrane protein in rare patients with dominant and possibly localized recessive forms of dystrophic epidermolysis bullosa. J Am Acad Dermatol (1990) 1.54

Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor. Antimicrob Agents Chemother (1997) 1.53

Progressive osseous heteroplasia. Arch Dermatol (1996) 1.51

Why patients don't follow medical advice: a study of children on long-term antistreptococcal prophylaxis. J Pediatr (1969) 1.50

The effect of salicylate on the metabolism of normal and stimulated human lymphocytes in vitro. J Clin Invest (1971) 1.50

Studies in the epidemiology and preventability of rheumatic fever. IV. A quantitative determination of compliance in children on oral penicillin prophylaxis. Pediatrics (1969) 1.49

Perianal pseudoverrucous papules and nodules in children. Arch Dermatol (1992) 1.48

Acrally occurring dermatofibrosarcoma protuberans in children and adults. J Dermatol Surg Oncol (1994) 1.42

Antimalarials for children: indications, toxicities, and guidelines. J Am Acad Dermatol (1993) 1.40

Urticarial vasculitis and Lyme disease. J Am Acad Dermatol (1990) 1.40

Nonprogressive scrotal hair growth in two infants. Pediatr Dermatol (1993) 1.40

Effect of growth hormone therapy on melanocytic nevi in survivors of childhood neoplasia. Arch Dermatol (1997) 1.40

Two sisters with telangiectases [corrected], spondyloepiphyseal dysplasia, hypothyroidism, neovascularization and tractional retinal detachments: a new entity? Pediatr Dermatol (1989) 1.39

Genotypic changes in human immunodeficiency virus type 1 associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapy. J Virol (1998) 1.38

Serum antibody titers to Candida albicans utilizing an immunofluorescent technic. Am J Clin Pathol (1968) 1.34

A mail-in technique for detecting penicillin in urine: application to the study of maintenance of prophylaxis in rheumatic fever patients. Pediatrics (1968) 1.34

Drug-induced hypersensitivity syndrome in pediatric patients. Pediatrics (2001) 1.29

The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection. J Infect Dis (2000) 1.26

Hypomelanosis of Ito (incontinentia pigmenti achromians): a neurocutaneous syndrome. J Pediatr (1977) 1.23

Eradication of rheumatic fever: an unfulfilled hope. Circulation (1970) 1.20

Pyoderma gangrenosum in infants and children. Pediatr Dermatol (1994) 1.19

Increased skin permeability in preterm infants. J Pediatr (1971) 1.18

Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies. AIDS (1999) 1.18

Improved estimates for HIV-1 clearance rate and intracellular delay. AIDS (1999) 1.17

'Membranous aplasia cutis' with hair collars. Congenital absence of skin or neuroectodermal defect? Arch Dermatol (1995) 1.17

The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. J Invest Dermatol (2001) 1.16

Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy. Immunol Lett (1999) 1.12

Report of an infant with GM1 gangliosidosis type I and extensive and unusual mongolian spots. Br J Dermatol (1981) 1.11

Hydroa vacciniforme. Diagnosis by repetitive ultraviolet-A phototesting. Arch Dermatol (1986) 1.10

Rapid, transient changes at the env locus of plasma human immunodeficiency virus type 1 populations during the emergence of protease inhibitor resistance. J Virol (1998) 1.10

Tissue expansion in a patient with extensive nevus comedonicus. Ann Plast Surg (1992) 1.10

Human immunodeficiency virus type-1 mRNA splicing pattern in infected persons is determined by the proportion of newly infected cells. Virology (1997) 1.08

Disseminated BCG in twin boys with presumed chronic granulomatous disease of childhood. Pediatrics (1971) 1.07

Eruptive vellus hair cysts. Arch Dermatol (1977) 1.07

Streptococcal pharyngitis: the case for penicillin therapy. Pediatr Infect Dis J (1994) 1.06

U1RNP positive neonatal lupus erythematosus: association with anti-La antibodies? Br J Dermatol (1995) 1.06

The relationship of transferrin and iron to serum inhibition of Candida albicans. J Invest Dermatol (1967) 1.06

The decline of rheumatic fever: role of medical intervention. Lewis W. Wannamaker Memorial Lecture. J Pediatr (1985) 1.06

Chondrodysplasia punctata. Conradi-Hünermann syndrome. Arch Dermatol (1977) 1.06

Circadian rhythms of blood minerals in humans. Science (1981) 1.05

A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome. N Engl J Med (1983) 1.04

Factors involved in treatment failures following oral penicillin therapy of streptococcal pharyngitis. J Pediatr (1968) 1.02

Ichthyosis follicularis with alopecia and photophobia. Arch Dermatol (1985) 1.02

Rheumatic heart disease in developing countries: the consequence of inadequate prevention. Ann Intern Med (1994) 1.02

Mongolian spots and GM1 type 1 gangliosidosis. J Am Acad Dermatol (1990) 1.00

Histiocytosis X: a seven-year experience at a children's hospital. J Am Acad Dermatol (1985) 0.99

Sacral hemangiomas and multiple congenital abnormalities. Arch Dermatol (1986) 0.99

Pupillotonia, hyporeflexia, and segmental hypohidrosis: autonomic dysfunction in a child. J Pediatr (1968) 0.99

Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Pediatr (1989) 0.99

Cutaneous polyarteritis nodosa of childhood. J Am Acad Dermatol (1994) 0.98

Nevoid basal cell carcinoma syndrome: bilateral ovarian fibromas in a 3 1/2-year-old girl. J Am Acad Dermatol (1986) 0.98

Accuracy of throat cultures processed in physicians' offices. J Pediatr (1970) 0.98

Management of streptococcal pharyngitis reconsidered. Pediatr Infect Dis (1985) 0.98

Factitial cheilitis in an adolescent. Pediatr Dermatol (1999) 0.96

Fatal cardiovascular disease and cutis laxa following acute febrile neutrophilic dermatosis. J Pediatr (1983) 0.96

Prenatal diagnosis of harlequin ichthyosis. Clin Genet (1980) 0.96

Acne: current concepts. Pediatrics (1978) 0.95

Pustulosis palmaris et plantaris: its association with chronic recurrent multifocal osteomyelitis. J Am Acad Dermatol (1985) 0.94

An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. Mol Med (2000) 0.94

Early surgical intervention in a patient with Kasabach-Merritt phenomenon. J Pediatr (2001) 0.92

Bacterial and candidal cutaneous infections in the neonate. Dermatol Clin (1986) 0.91